Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bellastella

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Endocrinological Investigation|June 4, 2020
Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?G Bellastella, M I Maiorino, K Esposito
Journal of Endocrinological Investigation|April 29, 2018
Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialogD Giugliano, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|October 7, 2018
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetesD Giugliano, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|March 18, 2018
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndromeM I Maiorino, G Bellastella, D Giugliano, et al.
International Journal of Clinical Practice|April 15, 2011
Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trialsD Giugliano, M Maiorino, G Bellastella, et al.
Current Pharmaceutical Design|May 27, 2006
Natural and synthetic retinoids in prostate cancerD Pasquali, V Rossi, G Bellastella, et al.
Journal of Endocrinological Investigation|April 8, 2019
Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysisD Giugliano, P Chiodini, M I Maiorino, et al.
Diabetes, Obesity & Metabolism|October 1, 2011
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patientsK Esposito, P Chiodini, G Bellastella, et al.
International Journal of Impotence Research|February 12, 2010
Determinants of erectile dysfunction in type 2 diabetesF Giugliano, M Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|September 28, 2012
Seasonal variations of plasma gonadotropin, prolactin, and testosterone levels in primary and secondary hypogonadism: evidence for an independent testicular roleG Bellastella, E Pane, S Iorio, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Endocrinological Investigation|June 4, 2020
Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?G Bellastella, M I Maiorino, K Esposito
Journal of Endocrinological Investigation|April 29, 2018
Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialogD Giugliano, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|October 7, 2018
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetesD Giugliano, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|March 18, 2018
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndromeM I Maiorino, G Bellastella, D Giugliano, et al.
International Journal of Clinical Practice|April 15, 2011
Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trialsD Giugliano, M Maiorino, G Bellastella, et al.
Current Pharmaceutical Design|May 27, 2006
Natural and synthetic retinoids in prostate cancerD Pasquali, V Rossi, G Bellastella, et al.
Journal of Endocrinological Investigation|April 8, 2019
Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysisD Giugliano, P Chiodini, M I Maiorino, et al.
Diabetes, Obesity & Metabolism|October 1, 2011
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patientsK Esposito, P Chiodini, G Bellastella, et al.
International Journal of Impotence Research|February 12, 2010
Determinants of erectile dysfunction in type 2 diabetesF Giugliano, M Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|September 28, 2012
Seasonal variations of plasma gonadotropin, prolactin, and testosterone levels in primary and secondary hypogonadism: evidence for an independent testicular roleG Bellastella, E Pane, S Iorio, et al.
Pageof 5